Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $1.78M | ﹤0.01% |
8,600
+1,100
| +15% | +$219K |
|
2102
Williams Companies
WMB
$92B
| $1.78M | ﹤0.01% |
38,900
-978,085
| -96% | -$43M |
|
2103
Adicet Bio
ACET
$78.4M
| $1.77M | ﹤0.01% |
76,975
-17,563
| -19% | -$393K |
|
|
NVRO
2104
DELISTED
NEVRO CORP.
NVRO
| $1.77M | ﹤0.01% |
316,919
-51,181
| -14% | -$358K |
|
2105
Colony Bankcorp
CBAN
$473M
| $1.76M | ﹤0.01% |
113,678
+18,600
| +20% | +$265K |
|
2106
Tidal Trust II Defiance Nasdaq 100 Weekly Distribution ETF
QQQY
$189M
| $1.76M | ﹤0.01% |
48,066
-54,934
| -53% | -$2.16M |
|
2107
Fossil Group
FOSL
$329M
| $1.75M | ﹤0.01% |
1,498,085
+12,500
| +0.8% | +$14.7K |
|
|
PINE
2108
Alpine Income Property Trust
PINE
$348M
| $1.75M | ﹤0.01% |
96,300
+54,741
| +132% | +$954K |
|
2109
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $1.75M | ﹤0.01% |
43,000
+25,217
| +142% | +$989K |
|
|
BOW
2110
Bowhead Specialty Holdings
BOW
$1.1B
| $1.75M | ﹤0.01% |
+62,300
| New | +$1.75M |
|
2111
Vanguard FTSE Europe ETF
VGK
$31.1B
| $1.74M | ﹤0.01% |
+24,500
| New | +$1.68M |
|
2112
Mesa Laboratories
MLAB
$593M
| $1.74M | ﹤0.01% |
13,400
+11,000
| +458% | +$1.29M |
|
2113
Vishay Intertechnology
VSH
$5.38B
| $1.74M | ﹤0.01% |
91,925
+31,514
| +52% | +$656K |
|
2114
LCNB Corp
LCNB
$283M
| $1.74M | ﹤0.01% |
115,216
+300
| +0.3% | +$4.42K |
|
|
FBMS
2115
DELISTED
The First Bancshares, Inc.
FBMS
| $1.74M | ﹤0.01% |
+54,000
| New | +$1.67M |
|
2116
Xenon Pharmaceuticals
XENE
$6.03B
| $1.73M | ﹤0.01% |
44,000
-48,900
| -53% | -$1.97M |
|
|
DHC
2117
Diversified Healthcare Trust
DHC
$2.03B
| $1.73M | ﹤0.01% |
413,300
+316,600
| +327% | +$1.07M |
|
2118
iShares MSCI Italy ETF
EWI
$1.08B
| $1.73M | ﹤0.01% |
+44,300
| New | +$1.66M |
|
|
TECX
2119
Tectonic Therapeutic
TECX
$682M
| $1.72M | ﹤0.01% |
56,897
-32,132
| -36% | -$587K |
|
|
EVRI
2120
DELISTED
Everi Holdings
EVRI
| $1.72M | ﹤0.01% |
131,200
-155,800
| -54% | -$1.84M |
|
2121
BayCom
BCML
$339M
| $1.72M | ﹤0.01% |
72,600
-7,900
| -10% | -$177K |
|
2122
Gossamer Bio
GOSS
$75.4M
| $1.72M | ﹤0.01% |
1,744,805
-301,795
| -15% | -$290K |
|
2123
Lindblad Expeditions
LIND
$2.2B
| $1.72M | ﹤0.01% |
185,899
+146,199
| +368% | +$1.36M |
|
|
SII
2124
Sprott
SII
$3B
| $1.72M | ﹤0.01% |
39,700
+13,500
| +52% | +$571K |
|
|
VOXR
2125
Vox Royalty Corp
VOXR
$359M
| $1.71M | ﹤0.01% |
567,300
+375,800
| +196% | +$1.03M |
|
Similar funds
Jim Simons's Q3 2024 Portfolio in Review
As of Q3 2024, Jim Simons held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Jim Simons's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Jim Simons added most to Microsoft in Q3 2024, an estimated $533M increase.
- Jim Simons's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Jim Simons fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Jim Simons's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Jim Simons opened 578 new positions and closed 539 in Q3 2024.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.